{
    "nctId": "NCT03030404",
    "briefTitle": "Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer",
    "officialTitle": "Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Stomach Neoplasms, Stomach Cancer, Gastric Adenocarcinoma and Proximal Polyposis of the Stomach (GAPPS), Hereditary Diffuse Gastric Cancer (HDGC), Familial Diffuse Gastric Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 684,
    "primaryOutcomeMeasure": "Characterization of the natural and clinical histories of hereditary gastric cancer syndromes",
    "eligibilityCriteria": "-INCLUSION CRITERIA:\n\n1. An individual, or their family members, with any of the following:\n\n   * Fulfills clinical criteria for Hereditary Diffuse Gastric Cancer (HGDC) syndrome or Gastric Adenocarcinoma and Proximal Polyposis of the Stomach (GAPPS) syndrome.\n   * Clinically suspicious personal or family medical history of gastric cancer or gastric cancer syndrome that warrants genetics evaluation.\n   * Current diagnosis of gastric cancer and a germline mutation associated with a known cancer syndrome or an associated family history of gastric cancer.\n   * Harbors a pathogenic germline mutation known to predispose to gastric cancer.\n   * First-degree relatives, regardless of family history or personal history of cancer, with a documented deleterious germline mutation (including but not limited to CDH1, CTNNA1, SDH) known to predispose to gastric tumors.\n   * Diagnosis or suspicion of a premalignant or malignant stomach lesion of suspected hereditary etiology.\n2. Age \\>= 2 years and older. Note: Patients under 18 years of age may only participate in research sample collection if the tissue acquisition is performed during a clinically indicated surgical procedure, and the sampling of tissue, blood, saliva or urine collection does not add risk to the clinically indicated procedures.\n3. Ability of subject or legally authorized representative (LAR) to understand and the willingness to sign a written informed consent document.\n\nEXCLUSION CRITERIA:\n\nNone.",
    "sex": "ALL",
    "minimumAge": "2 Years",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}